Crystallizer used for biomacromolecule crystallization, method and application thereof
A biomacromolecule and crystallization device technology, which is applied in the field of biomacromolecule crystallization devices, can solve the problems of amorphous precipitation and the inability to determine the crystallization concentration conditions of biomacromolecules, so as to reduce the amount of reagents and consumables, reduce costs, and expand the scope Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0072] choose as image 3 As shown in the crystallization plate, the crystallization plate has crystallization units 20 distributed in a 6×8 array, and each crystallization unit 20 has two titration areas 210 and one pool liquid area 220 . The screening solution is added to a titration area 210 of each crystallization unit 20 and then the crystallization plate is left to dry naturally at room temperature, that is, the screening solution is dried. Solid matter corresponding to the components of the screening fluid remains in the titration region 210 after drying. Into another titration area 210 in each crystallization unit 20, the same screening liquid corresponding to the previous operation is added again, but no drying treatment is required. Into the pool liquid area 220 of the crystallization unit 20, the same concentration but 50 times the screening liquid was also added.
[0073] Add the protein solution HutG to be crystallized into the crystallization area 210 in the cr...
Embodiment 2
[0098] The crystallization plates distributed in the form of a 6x8 array in which the pool liquid area and the crystallization area overlap were selected.
[0099] Screening solution:
[0100] Row A: 6% NaCl, 0.1M NaAc-HCl pH4.5
[0101] Row B: 7.5% NaCl, 0.1M NaAc-HCl pH4.5
[0102] Row C: 9% NaCl, 0.1M NaAc-HCl pH4.5
[0103] Row D: 0.02M calcium chloride dihydrate, 0.1M sodium acetate trihydrate pH4.6, 30% v / v (+ / -)-2-methyl-2,4-pentanediol
[0104] Row E: 0.2M Lithium Sulfate Monohydrate, 0.1M Tris Hydrochloride pH 8.5, 30% w / v Polyethylene Glycol 4000
[0105] Row F: 1.0M Na / K tartrate, 0.1M sodium 4-hydroxyethylpiperazineethanesulfonate pH7.5
[0106] Row G: 1.5M sodium formate, sodium acetate pH4.6
[0107]Row H: 1.0M Sodium Citrate, Sodium 4-Hydroxyethylpiperazineethanesulfonate pH7.5
[0108] crystallization process
[0109] Pre-drying:
[0110] 1 microliter of screening solution was added to each crystallization area 20, and the entire crystallization plate w...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 